Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

150.38 -9.40 (-5.88%)

Delayed Quote Updated: 11:29 AM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023

November 02, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing

October 31, 2023

From Twist Bioscience Corporation

Via Business Wire

TWIST ALERT: Bragar Eagel & Squire, P.C. is Investigating Twist Bioscience Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 05, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Why Shares of Twist Bioscience Are Up Friday ↗

August 04, 2023

The company reported improved financials in the third quarter.

Via The Motley Fool

Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

October 05, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations

October 03, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases

September 27, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Stock Soars After Q3 Report - Here's Why ↗

August 04, 2023

Twist Bioscience Corp (NASDAQ: TWST) reported Q3 sales increased 14% Y/Y to $63.7 million, beating the consensus of $60.71 million.

Via Benzinga

Twist Bioscience's Earnings Outlook ↗

August 03, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗

September 27, 2023

Via Benzinga

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗

September 21, 2023

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.

Via Benzinga

Analyst Ratings for Twist Bioscience ↗

July 13, 2023

Via Benzinga

Twist Bioscience to Present at Upcoming Investor Conferences

September 05, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases

August 31, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene

August 22, 2023

From Twist Bioscience Corporation

Via Business Wire

Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential ↗

August 11, 2023

DNA powers almost all biotechnology applications today. These leading DNA stocks are ready to reap the rewards of a growing industry.

Via InvestorPlace

Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023

August 07, 2023

From Twist Bioscience Corporation

Via Business Wire

Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗

August 04, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 04, 2023

Via Benzinga

Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results

August 04, 2023

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For August 4, 2023 ↗

August 04, 2023

Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.

Via Benzinga

Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023

July 20, 2023

From Twist Bioscience Corporation

Via Business Wire

2 Cathie Wood Growth Stocks That Could Make You Richer ↗

July 18, 2023

These two biotechs could be winning plays for aggressive investors.

Via The Motley Fool

Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research

July 18, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism

June 26, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Appoints Chet Gandhi as Chief Information Officer

June 20, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research

May 31, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at Upcoming Investor Conferences

May 24, 2023

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Appoints Robert Werner as Chief Accounting Officer

May 23, 2023

From Twist Bioscience Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.